PMC:7696151 / 23449-23691
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
700 | 34-42 | Species | denotes | patients | Tax:9606 |
701 | 59-76 | Species | denotes | hepatitis C virus | Tax:11103 |
709 | 114-117 | Chemical | denotes | HCQ | MESH:D006886 |
710 | 123-143 | Chemical | denotes | pegylated interferon | |
711 | 148-157 | Chemical | denotes | ribavirin | MESH:D012254 |
726 | 43-51 | Disease | denotes | infected | MESH:D007239 |
727 | 213-232 | Disease | denotes | chronic hepatitis C | MESH:D019698 |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T31 | 59-68 | Phenotype | denotes | hepatitis | http://purl.obolibrary.org/obo/HP_0012115 |
T32 | 213-230 | Phenotype | denotes | chronic hepatitis | http://purl.obolibrary.org/obo/HP_0200123 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T165 | 0-242 | Sentence | denotes | In a study including 120 Egyptian patients infected by the hepatitis C virus, it was seen that the combination of HCQ with pegylated interferon and ribavirin could improve biochemical and virological responses in chronic hepatitis C subjects. |